Intuitive Promotes President Dave Rosa to CEO

Intuitive announced that the company has promoted president Dave Rosa to CEO. Rosa will take office on July 1.

Current CEO Gary Guthart will become executive chair at that time, and current chair Craig Barratt will become lead independent director.

“Dave’s appointment as CEO is the culmination of the Board’s thoughtful succession planning, reflecting his instrumental role in establishing our strategy, guiding the development of our product pipeline, and expanding the company’s global footprint,” said Barratt. “We are confident he’s the right leader to drive the company’s next chapter of growth.”

“On behalf of Intuitive’s board, we thank Gary for his leadership of our company. We are fortunate that he will continue to play an important role as our next executive chair,” continued Barratt. “And, on behalf of our customers, we thank him for the role he has played in helping Intuitive pioneer advancements in robotic-assisted surgery that optimize care and deliver better patient outcomes.”

“It has been an honor and a privilege to serve as Intuitive’s CEO for the past 15 years, working alongside our talented and dedicated employees as we seek to advance minimally invasive care for healthcare teams and their patients around the world. Together, we’ve developed products and services that have made a positive difference for care teams and millions of their patients,” said Guthart.

Rosa is a 29-year veteran of Intuitive. He joined the company as its ninth employee in March 1996. Since then, he’s had leadership positions in engineering, clinical and product development, marketing, regulatory and quality affairs, and the commercial organization.

He founded Intuitive’s first clinical engineering and endoluminal groups, leading development and commercialization of the da Vinci SP robot and Ion robotic bronchoscopy system. He also launched the company’s Future Forward group, which identifies and develops new business opportunities.

Rosa took the role of executive VP and chief business officer in 2019, moving to chief strategy and growth officer three years later. He’s been Intuitive’s president since 2023 and became a member of the company’s board in 2024.

“We are at an exciting time with a significant opportunity to advance the work that customers care most about—the Quintuple Aim—improving patient outcomes, enhancing patient and care team experience, expanding patient access to care, and ultimately lowering the total cost to treat. I look forward to building on this work alongside the entire Intuitive team to deliver on these goals and drive value for all our stakeholders,” said Dave Rosa.